Is This Focused Large Cap Fund Worth Investing? Know Here…
Nov 04, 2017

Author: PersonalFN Content & Research Team

The investment objective of the Scheme is to provide long term capital appreciation by investing in concentrated portfolio of large cap focused equity and equity related instruments of up to 30 companies and balance in debt and money market instruments.

Summary

Type An open-ended equity scheme investing in maximum 30 stocks (predominantly large cap). Benchmark Index Nifty 100 Index
Min. investment: - Rs.5, 000/- & in multiples of Re. 1 thereafter

- Additional purchase: Rs 100 and in multiples of Re 1 thereafter

- Systematic Investment Plan
  • Monthly – Minimum Rs 500 per month for a minimum period of 12 months or Rs 1,000 per month for a minimum period of 6 months
  • Quarterly – Minimum Rs 1,500 per quarter for a minimum period of 4 quarters
Investments above the minimum amount mentioned, shall be made in multiples of Re 1 for all SIPs irrespective of frequency of SIP or the Option.
Plans:



Options:
  • Regular
  • Direct
  • Growth (default option)
  • Dividend
    • Dividend payout
    • Dividend Reinvestment
    • Dividend sweep
Face Value Rs 10 per unit Expense Ratio: Upto 3.00%
Entry Load Nil Exit Load: 1% for exit within 12 months from the date of allotment for the subscriptions received during the NFO period.
Issue Opens October 30, 2017 Issue Closes November 13, 2017

Investment Objective*

The investment objective of the Scheme is to provide long term capital appreciation by investing in concentrated portfolio of large cap focused equity and equity related instruments of up to 30 companies and balance in debt and money market instruments.

However, there can be no assurance that the investment objective under the Scheme will be realized

*Source: Scheme Information Document

Is this fund for you?

OFFERIDBI Focused 30 Equity Fund (IFEF) is an open-ended equity oriented fund from the stable of IDBI Mutual Fund. IFEF will predominantly invest in large-caps with a focus of building a portfolio of maximum 30 equity and equity related instruments and the balance in debt and money market instruments. Thus, IFEF is a concentrated fund with a mandate to invest upto 100% of its net assets into equity and equity related instruments.

Large caps are the companies that fall at the uppermost layer of the market capitalisation pyramid. Large cap companies are defined by the scheme as those among the top 100 companies (i.e. 1st – 100th company) in terms of full market capitalisation.

Often, the total market capitalisation of any market is skewed to a very few large companies. Large-cap companies act as bellwethers for some major industries of an economy. Large-caps are well-established businesses, have stable revenues, high market share and are usually well researched. Performance of large-caps is more predictable than their highly volatile midcap peers. They are considered to offer stable and sustainable returns over a period as against the mid-and-small caps that have potential to deliver high returns but are more volatile by nature.

Due to their huge size, the large-cap companies have the ability to weather unfavourable economic conditions. Hence, these companies command a premium over the mid-and-small cap companies despite growing at a slower pace. But since large-cap stocks have limited scope of growth as compared to smaller companies, investing in them at the reasonable valuations is imperative.

Being positioned as a focused large-cap fund, IFEF is expected to hold a compact portfolio of 30 large cap stocks. Hence, while the fund may provide stability to your portfolio especially during highly volatile market conditions, it may be suitable for investors with risk appetite, given its concentrated strategy. Investors should follow long-term approach and hold patience while investing in this fund.


How will the fund allocate its assets?

The asset allocation under normal circumstances will be as under:

Instruments Indicative allocations
(% of total assets)
Risk Profile
High/Medium/Low
Minimum Maximum
"Equity and Equity related instruments
( which are not exceeding 30 companies) #"
65 100 High
Debt and Money market instruments* 0 35 Low to Medium
(*Source: Scheme Information Document)


$ The Scheme shall invest in equity and equity related instruments of companies across market capitalization.
# Including derivatives instruments to the extent of 50% of the Net Assets as permitted by SEBI Regulations
*Investment in Securitized debt (excluding foreign securitized debt), if undertaken, would not exceed 20% of the net assets of the Scheme.

Further it is stated in the offer document that:

  • The Scheme will have maximum of 30 stocks in the portfolio.
  • Investment in Derivative instruments will not exceed 50% of the net assets of the Scheme. The total exposure related to option premium paid will not exceed 20% of the net assets of the scheme.
  • Investment in derivatives shall be for hedging, portfolio balancing and such other purposes as maybe permitted from time to time.
  • The Scheme may also invest in Initial Public Offerings (IPOs).
  • The Scheme does not propose to invest in Securitized Debt/ADRs/ GDRs and foreign securities.

What investment strategies will the fund follow?

In the endeavour to achieve the investment objective set out, IFEF will follow the below mentioned investment strategy…

For Equity Investments:

With an objective to provide long-term capital growth, the scheme aims to build a concentrated portfolio of equity & equity related instruments of up to 30 large cap companies. The scheme seeks to tap onto the best opportunities present in the market without any sectoral bias. It will follow a bottom-up approach for stock-picking and choose companies across sectors.

IFEF will primarily focus on the companies that have demonstrated characteristics such as market leadership, strong financials and quality management, and have the potential to create wealth for their shareholders by delivering steady performance through the ups and downs of the market.

The focus would be to build a portfolio of both value and growth company stocks. These stocks would be further analysed by considering their business fundamentals, company’s financial strength, industry structure, management quality, future earnings expectations and sensitivity of earnings.

For Derivative Investments:

The Scheme may use either Index based derivatives and/or their constituent based derivatives for the purpose of hedging and balancing. The Scheme may specifically use Stock futures as an alternative to investing in particular stocks that form a part of the index where either the liquidity is low or the impact cost is high in the cash market.


Fund Manager Profile

IFEF will be managed by: Mr V. Balasubramanian.

Mr V. Balasubramanian has over 37 years of experience of which 19 years have been in the mutual fund Industry, and 8 years in Treasury of a nationalised bank. He holds a Master's degree in Commerce (M. Com) and CAIIB degree from the Indian Institute of Banking & Finance. Prior to joining IDBI Mutual Fund, he's worked as a Senior Manager of the Treasury branch of Indian Bank. He also has experience in Fund Accounting and Software Development for fund accounting. Prior to joining IDBI Mutual Fund, he was a Senior Manager of the Treasury branch of Indian Bank.

At IDBI he currently manages IDBI Equity Advantage Fund (previously known as IDBI Tax Saving Fund), and IDBI Prudence Fund (Equity portion).


Fund Outlook

On evaluating the investment objective and strategy, it is evident that the fortune of IFEF will be closely linked to 30 large cap stocks which fund manager would construct at any given point of time. Being a concentrated fund, a lot would depend on fund manager’s portfolio construction style.

With the market soaring to new highs, market valuations too are moving to the grossly overvalued zone. If the positives fail to outweigh the negatives, the market may soon head lower. At such times, large-caps will be better poised to handle market volatility vis-à-vis mid-and-small caps.

Stable businesses, greater market share, quality of management and the sustainability prospects are factors that seem convincing to take exposure to large-caps at present. Large blue-chip companies with strong balance sheets and proven track records could help ride the wave of short-term volatility to a certain extent. Therefore, diversified equity funds with a predominant large-cap allocation can offer stability to your investment portfolio. At the same time, funds that are restrictive in their investment approach or those funds that invest only in a concentrated portfolio of large-caps can be volatile and may fail to generate adequate returns over the long term.


DISCLOSURE AS PER SECURITIES AND EXCHANGE BOARD OF INDIA (RESEARCH ANALYSTS) REGULATIONS, 2014

About the Company including business activity

Quantum Information Services Private Limited (QIS) was incorporated on December 19, 1989.

QIS was promoted by Mr. Ajit Dayal with an objective of providing value-based information / views on news related to equity markets, the economy in general, sector analysis, budget review and various personal products and investments options available to the Public. It was the first company to start equity research on an institutional level.

PersonalFN' is a service brand of QIS and was started in the year 1999. In 1999, the Company registered the Domain name www.personalfn.com for providing information on mutual funds and personal financial planning, financial markets in general, etc and services related to financial planning and research in various financial instruments including mutual funds, insurance and fixed income products to customers. It offers asset allocation and researched investment recommendations through its financial planning services.

Quantum Information Services Private Limited (QIS) is registered as Investment Adviser under SEBI (Investment Adviser) Regulations, 2013 and having Registration No.: INA000000680. In terms of second proviso to Regulation 3 (1) of SEBI (Research Analysts) Regulations, 2014 the Company is not required to obtain Certificate of registration from SEBI.

Disciplinary history

There are no outstanding litigations against the Company, it subsidiaries and its Directors.

Terms and condition on which its offer research report
For the terms and condition for research report click here.

Details of associates

  1. Money Simplified Services Limited;
  2. PersonalFN Insurance Services India Limited ;
  3. Equitymaster Agora Research Private Limited;
  4. Common Sense Living Private Limited;
  5. Quantum Advisors Private Limited;
  6. Quantum Asset Management Company Private Limited;
  7. HelpYourNGO Private Limited;
  8. HelpYourNGO Foundation;
  9. Natural Streets for Performing Arts Foundation;
  10. Primary Real Estate Advisors Private Limited;
  11. Rahul Goel;
  12. I V Subramaniam.

Disclosure with regard to ownership and material conflicts of interest
 

  1. Neither QIS, it's Associates, Research Analyst or his/her relative have any financial interest in the subject Company, except QIS receives fees for providing research to Quantum Equity Fund of Fund (QEFoF) which is Fund of Fund scheme managed by QMF and our associates has financial interest in the subject company.
  2. Neither QIS, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report.
  3. Neither QIS, it's Associates, Research Analyst or his/her relative has any other material conflict of interest at the time of publication of the research report except that QIS is, as per SEBI (Mutual Funds) Regulations 1996, an associate / group Company of Quantum Asset Management Company Private Limited and Trustees and Sponsor of Quantum Mutual Fund (QMF) and to that extent there may be conflict of interest while recommending any schemes of QMF. However any such recommendation or reference made is based on the standard evaluation and selection process, which applies uniformly for all Mutual Fund Schemes. The payment of commission (upfront /annualized & trail), if any, for any Schemes by QMF to QIS is also at arm's length and as per prevailing market practices.
     

Disclosure with regard to receipt of Compensation

  1. Neither QIS nor it's Associates have any compensation from the subject Company in the past twelve months.
  2. Neither QIS nor it's Associates have managed or co-managed public offering of securities for the subject Company in the past twelve months.
  3. Neither QIS nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject Company in the past twelve months.
  4. Neither QIS nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months, except that QIS had receive fees for services under sponsorship agreement from Franklin Templeton Asset Management India Pvt. Ltd.
  5. Neither QIS nor it's Associates have received any compensation or other benefits from the subject Company or third party in connection with the research report
     

General disclosure

  1. The Research Analyst has not served as an officer, director or employee of the subject Company.
  2. QIS or the Research Analyst has not been engaged in market making activity for the subject Company.
     

Subject Company means Mutual Fund Schemes

Quantum Information Services Pvt. Ltd. 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021. Tel: +91 22 6136 1200
Website : www.personalfn.com CIN: U65990MH1989PTC054667

© Quanutm Information Services Pvt. Ltd. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of PersonalFN is strictly prohibited and shall be deemed to be copyright infringement.

Disclaimer: Quantum Information Services Pvt. Limited (PersonalFN) is not providing any investment advice through this service and, does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities. All content and information is provided on an 'As Is' basis by PersonalFN. Information herein is believed to be reliable but PersonalFN does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. PersonalFN and its subsidiaries / affiliates / sponsors or employees, personnel, directors will not be responsible for any direct / indirect loss or liability incurred by the user as a consequence of him or any other person on his behalf taking any investment decisions based on the contents and information provided herein. This is not a specific advisory service to meet the requirements of a specific client. Use of this information is at the user's own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. All intellectual property rights emerging from this newsletter are and shall remain with PersonalFN. This is for your personal use and you shall not resell, copy, or redistribute this newsletter or any part of it, or use it for any commercial purpose. The performance data quoted represents past performance and does not guarantee future results. As a condition to accessing PersonalFN's content and website, you agree to our Terms and Conditions of Use, available here.

Quantum Information Services Pvt. Ltd. Regd. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021 Corp. Office: 103, Regent Chambers, 1st Floor, Nariman Point, Mumbai - 400 021. Email: info@personalfn.com CIN: U65990MH1989PTC054667

SEBI-registered Investment Adviser. Registration No. INA000000680, SEBI (Investment Advisers) Regulation, 2013



Add Comments

Daily Wealth Letter


Fund of The Week


Knowledge Center


Money Simplified Guides (FREE)


Mutual Fund Fact Sheets


Tools & Calculators